Caspase-1 transcripts in failing human heart after mechanical unloading

Area of Science:

• Cardiovascular Research
• Molecular Biology
• Inflammation Studies

Background:

• Caspase-1 (Casp-1) plays a key role in cardiovascular diseases (CVDs) by promoting inflammation and cardiomyocyte loss.
• Targeting Casp-1 is a potential strategy to prevent the progression of heart failure (HF).

Purpose of the Study:

• To investigate the impact of Left Ventricular Assist Device (LVAD) implantation on cardiac inflammation and apoptosis.
• To assess the modulation of Caspase-1 (Casp-1) expression levels following LVAD implantation.

Main Methods:

• Cardiac tissue samples were obtained from end-stage HF patients before and after LVAD implantation.
• Samples from heart transplant recipients (HTx) on medical therapy served as controls.
• Real-time PCR was used to evaluate the cardiac expression of Casp-1 and its inhibitors, COP and ICEBERG.

Main Results:

• Caspase-1 (Casp-1) expression was significantly elevated in patients pre-LVAD compared to HTx controls (p=0.006).
• ICEBERG levels were markedly reduced in pre-LVAD patients relative to HTx controls (p<0.001).
• No significant difference in COP expression was observed between groups.

Conclusions:

• LVAD implantation is associated with a distinct Caspase-1 (Casp-1) system profile in heart failure patients.
• Inflammation appears to be a critical factor in a negative feedback loop regulating Casp-1 signaling and downstream apoptosis.